Hence, our data reinforce a key role for this novel AEP-ATR axis in genotoxic tolerance in BC, suggesting the possibility of combining AEP inhibitors with current radiotherapy or chemotherapy approaches to increase treatment efficiency in AEPhigh/ATRlow patients. The gene discussed is LGMN; the disease is breast cancer.